BRIEF-Ranbaxy to resume manufacture of generic Lipitor for U.S.
Feb 22 (Reuters) - Ranbaxy Laboratories Ltd : * Says resuming manufacture of generic lipitor for U.S.
- Exclusive: Angry with Washington, 1 in 4 Americans open to secession
- Scots spurn independence in historic vote, devolution battle begins |
- Eight bodies found after attack on Guinea Ebola education team
- Alibaba surges 38 percent on massive demand in market debut |
- Special Report: Scotland stays in UK, but Britain faces change